DRUG
Bright Minds Biosciences Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$28.380
Kõrge
$28.380
Madal
$28.380
Maht
0.01M
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika
Seotud uudised
Bright Minds Biosciences to Present at the 2025 Jefferies Global Healthcare Conference
NEW YORK and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. ("Bright Minds," "BMB" or the "Company") (NASDAQ:DRUG), a pioneering company focused on developing highly
Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside
Chardan initiates Bright Minds with a Buy rating, citing over $1 billion sales potential for epilepsy drug BMB-101 despite limited clinical data.
Seotud aktsiad
CORT
Corcept Therapeutics Incorporated
BTE
Baytex Energy Corp Common Shares
TFII
TFI International Inc. Common Shares
SA
Seabridge Gold Inc. Ordinary Shares (Canada)
PRMW
Primo Water Corporation
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.